Impact of Holistic Lifestyle Modification and Emotional Wellness Counseling on Glaucoma Progression in Middle-Aged Patients: A Retrospective Observational Study

Glaucoma is a chronic progressive optic neuropathy and remains a leading cause of irreversible blindness worldwide1. Although intraocular pressure (IOP) reduction is the cornerstone of glaucoma management, progression may still occur despite adequate IOP control, suggesting the involvement of non-IOP-dependent factors such as vascular dysregulation, systemic comorbidities, oxidative stress, and psychological stress2.

Emerging evidence suggests that oxidative stress and vascular dysregulation play a central role in glaucomatous optic neuropathy3,4 Additionally, systemic conditions such as diabetes mellitus and hypertension have been associated with increased glaucoma risk and progression.2

Lifestyle factors and emotional wellbeing influence medication adherence, systemic disease control, and overall quality of life. Medication non-adherence remains a major barrier in glaucoma management.5

Physical activity has been shown to influence intraocular pressure and ocular perfusion.^7 Therefore, integrating lifestyle modification may complement standard IOP-lowering therapy.^2,7

Early identification of glaucoma provides an opportunity to integrate lifestyle modification and emotional resilience strategies alongside conventional therapy. Current clinical guidelines emphasize early detection and long-term monitoring of glaucoma.6 Screening for glaucoma beginning around 35 years of age may allow timely diagnosis and behavioral modification when interventions are more feasible and impactful.2,6

This study evaluates the role of holistic lifestyle modification and emotional wellness counseling as supportive measures in younger glaucoma patients

Baseline Characteristics

The study included 100 patients (56 males, 44 females) with a mean age of 43 ± 3 years. Sixty-two patients (62%) had POAG and 38 patients (38%) had PACG. Mean follow-up duration was 22 ± 4 months.

Systemic comorbidities were common: 46% had diabetes mellitus, 52% had hypertension, and 28% had both. All patients demonstrated good medication compliance.

Structural and Functional Outcomes

Visual field analysis was performed using the Humphrey Field Analyzer. Only reliable fields were included (fixation losses <20%, false positives <15%, false negatives <15%).

Based on serial OCT RNFL and HVF assessment:

·       Improvement group: 20 patients (20%) showed mild improvement in RNFL thickness (2–4 µm) with improvement in MD and stabilization or reduction in PSD.

·       Stable group: 70 patients (70%) demonstrated stable RNFL thickness and stable MD, PSD, and VFI.

·       Progression group: 10 patients (10%) showed RNFL thinning and worsening visual field parameters, including MD decline, increased PSD, and reduced VFI despite optimal therapy.

Medication Burden

The mean number of antiglaucoma medications at baseline was 2.1 ± 0.6. During follow-up, 22 patients (22%) were able to reduce at least one antiglaucoma medication while maintaining target IOP. No patient required surgical escalation.

Table 1. Baseline demographic and clinical characteristics

Table 2. Structural and functional outcomes at follow-up

This retrospective study demonstrates that holistic lifestyle modification and emotional wellness counseling, when integrated with standard glaucoma therapy, are associated with high rates of disease stability in a younger glaucoma population.

The role of vascular dysregulation, oxidative stress, and systemic health in glaucoma progression has been increasingly recognized in recent years, supporting the concept that non-IOP factors influence disease trajectory.²˒³˒⁴

A key strength of this study is the deliberate focus on patients below 50 years of age. Lifestyle modification is more practical and meaningful in younger individuals, who show higher motivation, better systemic disease control, improved medication adherence, and greater engagement in physical activity. These factors collectively influence long-term glaucoma outcomes.

The findings also highlight the importance of early glaucoma screening, ideally from 35 years of age. Early diagnosis enables timely initiation of lifestyle modification and emotional resilience strategies, which may positively influence disease trajectory5. This preventive approach is especially relevant in a chronic disease like glaucoma, where long-term adherence and behavioral factors play a significant role.

The observed mild improvement in RNFL and visual field parameters in 20% of patients should be interpreted cautiously and may reflect disease stabilization, improved test reliability, and neuroadaptation rather than true reversal. Nevertheless, the high proportion of patients showing non-progression supports the role of integrative care as an adjunct to conventional management.

The importance of early detection and sustained monitoring in preventing visual disability is strongly emphasized in current international clinical practice guidelines.⁶

Limitations

The retrospective design limits causal inference. The absence of a control group and reliance on medical record documentation are additional limitations. Larger prospective studies are required to validate these findings.

Early identification of glaucoma in younger individuals, combined with holistic lifestyle modification and emotional wellness counseling, may support disease stability and reduce treatment burden. Emphasizing early screening and preventive strategies could play a meaningful role in long-term glaucoma management.